2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Tachycardia, Supraventricular
1
Heart Failure
1
Cardiotoxicity
1
Atrial Fibrillation
1
Arrhythmias, Cardiac
1
Interventions
Surveys and Questionnaires
543
Blood Specimen Collection
447
Surgical Procedures, Operative
164
Observation
152
Drug Therapy
143
Radiotherapy
142
Interviews as Topic
139
Gene Expression Profiling
129
Biopsy
117
Magnetic Resonance Spectroscopy
116
Immunohistochemistry
112
Data Collection
95
Polymerase Chain Reaction
87
Specimen Handling
81
Amplified Fragment Length Polymorphism Analysis
81
Bevacizumab
79
Microarray Analysis
76
Flow Cytometry
69
Neoadjuvant Therapy
68
Watchful Waiting
67
Magnetic Resonance Imaging
65
Immune Checkpoint Inhibitors
62
Nivolumab
60
Immunotherapy
57
Therapeutics
55
Reverse Transcriptase Polymerase Chain Reaction
52
pembrolizumab
50
Ultrasonography
47
Positron Emission Tomography Computed Tomography
47
Hematologic Tests
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Gonadal Steroid Hormones
×
Clear all
NCT03243604
2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed
1,717 enrolled